5 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
Follow Andres J. M. Ferreri: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis Factor NGR-hTNF, RITUXIMAB, Doxorubicin - Lymphoma, Large B-Cell, Diffuse | Phase 2 | Completed | Andres J. M. Ferreri | 28 | 2016-01-27 | 2022-08-03 |
| Salvage Therapy With High Dose Oral Clarithromycin in Relapsed or Refractory Extranodal Marginal Zone Lymphoma clarithromycin, oral, high dose - Lymphoma | Phase 2 | Completed | Andres J. M. Ferreri | 23 | 2012-01-01 | 2022-08-12 |
| Intralesional Rituximab for the Treatment of Conjunctival Indolent Lymphoma intralesional rituximab, supplemental autologous serum - Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma | Phase 2 | Completed | Andres J. M. Ferreri | 20 | 2011-12-01 | 2022-08-04 |
| Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia Romiplostim - Non-Hodgkin Lymphoma | Phase 2 | Completed | Andres J. M. Ferreri | 3 | 2011-11-01 | 2022-08-12 |
| Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma Induction Phase, Consolidation Phase (on day +50), Intensification phase - HIV, Burkitt's Lymphoma | Phase 2 | Completed | Andres J. M. Ferreri | 19 | 2011-11-01 | 2022-08-04 |
Burkitt Lymphoma (1) · Lymphoma (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Non-Hodgkin (1) · Recurrence (1)
Rituximab (2) · Clarithromycin (1) · Complement System Proteins (1) · Cyclophosphamide (1) · Cytarabine (1) · Doxorubicin (1) · Prednisone (1) · Transplantation Conditioning (1) · Transplantation, Autologous (1) · Vincristine (1) · deltacortene (1) · romiplostim (1) · tumor necrosis factor-alpha, CNGRC fusion protein, human (1)
Italy (5)